Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 1HM market cap is 1.03B. The company's latest EPS is USD -1.0734 and P/E is -7.35.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 98.38M | 154.34M | 185.31M | 170.28M | 178.96M |
| Operating Income | -152.82M | -208.97M | -200.19M | -201.61M | -162.55M |
| Net Income | -146.23M | -207.28M | -200.19M | -225.25M | -159.49M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.12B | 923.34M | 856.62M | 661.13M | 539.38M |
| Total Liabilities | 373.15M | 319.24M | 392.52M | 352.86M | 336.89M |
| Total Equity | 743.27M | 604.1M | 464.1M | 308.28M | 202.49M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -149.68M | -192.73M | -183.95M | -156.32M | -95.21M |
| Investing | -117.04M | 181.21M | 2.91M | 129.65M | 77.79M |
| Financing | 293.59M | 27.15M | 132.27M | 2.25M | 241k |
| Market Cap | 1.03B |
| Price to Earnings Ratio | -7.35 |
| Price to Sales Ratio | 6.55 |
| Price to Cash Ratio | 24.47 |
| Price to Book Ratio | 5.79 |
| Dividend Yield | - |
| Shares Outstanding | 148.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 433 |
| 52 Week Change | 191.16% |
| 52 Week High | 8.41 |
| 52 Week Low | 2.38 |
| Spread (Intraday) | 0.18 (2.56%) |
| Company Name | Adaptive Biotechnologies Corp |
| Address |
711 capitol way s ste 204 olympia, washington 98501 1267 |
| Website | https://www.adaptivebiotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
